Endolaser: Skin Tightening and Local Contouring – Ataşehir, Istanbul

What is endolaser?

Endolaser is a minimally invasive technique delivering laser energy beneath the skin through a fine optical fibre. It may be planned to improve skin laxity and limited local fat deposits. Unlike an open lift, it does not involve long incisions, but small access points and aftercare are still required. Local anaesthesia is commonly used.

It may be considered for adults with mild-to-moderate laxity and limited fat under the chin, along the jawline, on the neck or in selected body areas. It is not a general weight-loss treatment or equivalent to surgical lifting for advanced laxity.

At our Ataşehir practice, general surgeon Op. Dr. Salim Balin plans treatment after assessing the skin, fat distribution and relevant nerve and vascular anatomy.

How does endolaser work?

Laser energy produces controlled heating beneath the skin. The aims include connective-tissue contraction, gradual collagen remodelling and, depending on technique, reduced local fat. Response depends on the device, settings, area and starting condition.

Published reports describe systems such as 1470 nm diode lasers and fine fibres in the 200–400 micrometre range. These are examples from specific systems in the literature, not a statement of this practice’s device specifications. The proposed equipment, fibre and technique are explained before treatment.

Skin-temperature monitoring and equipment-appropriate protection are important. Endolaser does not necessarily remove fat by suction as conventional liposuction does. Adding aspiration changes the procedure’s scope and recovery.

• Subdermal access: A fine fibre is introduced through a small entry point. This differs from laser treatment delivered only from the skin surface.
• Fat effects: Suitable techniques can aim for thermal disruption of fat cells followed by tissue remodelling. The amount of reduction cannot be assumed to be the same for everyone.
• Connective tissue: Heating may produce some early contraction, although swelling also affects the initial appearance.
• Collagen remodelling: Tissue changes may continue for months, so assessment should not rely solely on the appearance immediately after treatment.

Which areas may be treated?

Endolaser is often assessed for the lower face and neck. Body treatments require separate selection of device, technique and aim. Planning and recovery differ by area. The links below lead to area-specific guides.

When is treatment unsuitable or not recommended?

This elective procedure is avoided in certain circumstances; in others, a different approach may be more suitable. Conditions, medicines and previous procedures are reviewed in detail.

• Pregnancy and breastfeeding.
• Active infection, significant acne flare or open wounds in the treatment area.
• Uncontrolled diabetes or systemic disease, bleeding disorders or significant wound-healing problems.
• Warfarin or other anticoagulants: treatment while taking these medicines is not recommended in this clinic pathway. Do not stop them independently; any plan requires coordination with the prescriber.
• Recent fillers, especially permanent fillers, or active autoimmune skin disease at the site require further assessment.
• Marked excess skin and advanced laxity may be better addressed surgically.
• General excess weight: endolaser is not a weight-loss treatment; weight management may need to come first.

Recovery and when results may appear

Some early contraction may be noticed, although swelling affects the initial appearance. Changes from collagen remodelling may develop over three to six months. This timeline is approximate and varies between patients.

Avoid strenuous exercise, saunas, steam rooms and excessive heat initially; agree when to resume with your clinician. Sun protection, access-site care and follow-up matter. Added aspiration, larger areas or sedation may require longer recovery.

Maintenance depends on age, skin quality, technique and weight stability. Fat reduction does not guarantee that the area will never gain fat again; weight gain can enlarge remaining fat tissue and natural ageing continues.

1. First one to three days: Swelling, tenderness and mild bruising may occur. After limited treatment, light activities may resume the same or following day; compression or swelling can require a one-to-two-day pause.
2. First week: Swelling may begin to settle. Facial or body compression is used only as directed for the specified duration.
3. Weeks two to four: Bruising and swelling commonly subside. Firmness or altered sensation may persist; persistent or worsening symptoms require review.
4. Months one to three: Contour changes and tissue response may become more apparent.
5. Months three to six: The result is assessed clinically, with further options discussed if needed.

Risks and possible adverse effects

Endolaser is a medical intervention and is not risk-free. Experience, patient selection and safety measures aim to reduce risk, not eliminate it.

• Often temporary symptoms: Swelling, redness, bruising, tenderness, firmness or numbness.
• Other possible complications: Burns, access-site scars, infection, contour irregularities and fluid collections.
• Area-specific risks: Nerve injury around the lower face or jawline can cause smile asymmetry or weakness. Some cases are temporary, but persistent injury cannot be excluded.

Endolaser, liposuction or lifting surgery?

The choice depends on fat volume, excess skin and degree of laxity. Surgical alternatives should be discussed when endolaser is unlikely to be sufficient. This is a general comparison, not a personal recommendation.

Scientific evidence and realistic expectations

Although published reports describe encouraging findings, much of the evidence involves small samples, short follow-up and limited comparisons. The same efficacy or durability cannot be assumed across areas, devices and techniques.

The 2024 horizontal-neck-line study by Nilforoushzadeh and colleagues assessed ten participants and reported improvements in some measurements at three months after one treatment. Its small sample and lack of a control group limit generalisation and long-term safety conclusions.

This treatment may be known by different names; “endolaser” is the general term for fibre-delivered subdermal laser treatment. Different devices and techniques are not equivalent; the proposed system is explained in consultation.